About US
Contact us
-
Amazon in talks with generic drugmakers including Mylan, Sandoz about pharma play: reportThe buzz about Amazon's potential play in the drug business has persisted despite the e-retailing giant's refusal to comment. Now, CNBCreportsthe company has had discussions with generic drugmakers—My2017/12/1
-
Bristol-Myers Squibb takes Opdivo to China's FDA after lung cancer survival winBristol-Myers Squibb is still searching for an Opdivo approval in the all-important first-line lung-cancer space. But in the meantime, it Friday touted strong results in previously treated Chinese pat2017/12/1
-
As lawmakers blast pharma ties, HHS nominee Azar pledges to fight high pricesDrug prices took center stage at a contentious hearing for former Eli Lilly executive Alex Azar, who's up for the top job at the Department of Health and Human Services. During the hearing, many sen2017/11/30
-
J&J, Gates Foundation and NIAID launch efficacy study for their 'global' HIV vaccineRight on the heels of the world's first large-scale HIV vaccine trial in several years, Johnson & Johnson and partners on Thursday pushed their promising "mosaic" vaccine candidate into efficacy2017/11/30
-
One big Novartis takeaway from Entresto's slow start? Heart failure doesn't work like oncologyNovartis heart failure med Entresto, which got a slow start after launching to multibillion-dollar sales expectations, would have seen faster uptake, company executives figure—if only it had been an o2017/11/29
-
OTC Viagra: Pfizer snags nod for nonprescription sales of the little blue pill for men in the U.K.Pfizer has won afirst approval for OTC Viagra. Viagra Connect, the Pfizer OTC name for its blockbuster erectile dysfunction drug, has been approved for sale in the U.K. The Medicine and Healthcare2017/11/29
-
Pfizer, Merck KGaA's Bavencio flops in 'high-risk' stomach cancer trialPfizer and Merck KGaA are working to carve out a niche for immuno-oncology drug Bavencio in a crowded field. But a failed phase 3 trial in advanced stomach cancer just dinged their ambitions. Tuesd2017/11/28
-
Alkermes hit with 3 gender discrimination lawsuits from former staffersAs biopharma grapples with a widespread gender diversity problem, Alkermes faces three lawsuits alleging discriminatory treatment toward female employees, with one suit even claiming it's the company'2017/11/28
-
Novartis looks to poach Advair patients with positive Ultibro switching dataNovartis is looking to snatch patients from GlaxoSmithKline with Advair rival Ultibro Breezhaler. And it has some new data in hand that could help convince doctors and patients to make the switch.2017/11/27
-
As Advair struggles, GlaxoSmithKline seeks expanded label for blockbuster-to-be TrelegyFacing the prospect of generic competition to respiratory superstar Advair—and as the blockbuster's sales falter under pricing pressure—GlaxoSmithKline is pushing to grow new drug Trelegy Ellipta by2017/11/27